Literature DB >> 30885663

ASCO gastrointestinal cancers symposium: Perspectives on older adults with gastrointestinal malignancies.

Sukeshi Patel Arora1, Anne M Noonan2, Noam Vanderwalde3, Grant R Williams4.   

Abstract

Entities:  

Keywords:  ASCO; Age; Elderly; Gastrointestinal cancer; Older adult

Year:  2019        PMID： 30885663      PMCID： PMC6535130          DOI： 10.1016/j.jgo.2019.03.003

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN： 1879-4068            Impact factor:   3.599


× No keyword cloud information.
  5 in total

1.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

Authors:  Supriya G Mohile; William Dale; Mark R Somerfield; Mara A Schonberg; Cynthia M Boyd; Peggy S Burhenn; Beverly Canin; Harvey Jay Cohen; Holly M Holmes; Judith O Hopkins; Michelle C Janelsins; Alok A Khorana; Heidi D Klepin; Stuart M Lichtman; Karen M Mustian; William P Tew; Arti Hurria
Journal:  J Clin Oncol       Date:  2018-05-21       Impact factor: 44.544

2.  Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE).

Authors:  Grant R Williams; Kelly M Kenzik; Mariel Parman; Mustafa Al-Obaidi; Liton Francisco; Gabrielle B Rocque; Andrew McDonald; Ravi Paluri; Rudolph M Navari; Lakshmin Nandagopal; Olumide Gbolahan; Crystal Young-Smith; Matthew Robertson; Smita Bhatia
Journal:  J Geriatr Oncol       Date:  2019-04-18       Impact factor: 3.599

3.  Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Authors:  Thierry André; Corrado Boni; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Andrea Bonetti; Philip Clingan; John Bridgewater; Fernando Rivera; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

4.  A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).

Authors:  Nadja M Meindl-Beinker; Johannes Betge; Tobias Gutting; Elke Burgermeister; Sebastian Belle; Tianzuo Zhan; Nadine Schulte; Martin Maenz; Matthias P Ebert; Nicolai Haertel
Journal:  BMC Cancer       Date:  2019-03-14       Impact factor: 4.430

5.  Increased Inflammatory Response in Old Mice is Associated with More Severe Neuronal Injury at the Acute Stage of Ischemic Stroke.

Authors:  Fanxia Shen; Lidan Jiang; Frank Han; Vincent Degos; Shengdi Chen; Hua Su
Journal:  Aging Dis       Date:  2019-02-01       Impact factor: 6.745
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.